Abhya Gupta

2.1k total citations · 1 hit paper
39 papers, 1.4k citations indexed

About

Abhya Gupta is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology and Allergy. According to data from OpenAlex, Abhya Gupta has authored 39 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 7 papers in Immunology and Allergy. Recurrent topics in Abhya Gupta's work include Asthma and respiratory diseases (8 papers), Respiratory and Cough-Related Research (7 papers) and Neonatal Respiratory Health Research (6 papers). Abhya Gupta is often cited by papers focused on Asthma and respiratory diseases (8 papers), Respiratory and Cough-Related Research (7 papers) and Neonatal Respiratory Health Research (6 papers). Abhya Gupta collaborates with scholars based in Germany, United States and United Kingdom. Abhya Gupta's co-authors include Kevin M. Brown, Paul W. Noble, Ganesh Raghu, David M. Hansell, Nolwenn Juhel, Kevin Flaherty, Roland M. du Bois, Ulrich Costabel, Michèle Brun and Luca Richeldi and has published in prestigious journals such as New England Journal of Medicine, Blood and The Journal of Immunology.

In The Last Decade

Abhya Gupta

37 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis

2011 811 citations Luca Richeldi, Ulrich Costabel et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Abhya Gupta Germany	13	920	459	216	171	163	39	1.4k
N. Hizawa Japan	23	554 0.6×	641 1.4×	334 1.5×	325 1.9×	67 0.4×	39	1.4k
Hideki Inoue Japan	23	789 0.9×	653 1.4×	283 1.3×	129 0.8×	44 0.3×	68	1.5k
Djuro Kosanovic Germany	22	844 0.9×	196 0.4×	378 1.8×	179 1.0×	58 0.4×	62	1.4k
Poornima Mahavadi Germany	22	1.1k 1.1×	167 0.4×	462 2.1×	116 0.7×	60 0.4×	43	1.6k
Dariusz Zakrzewicz Germany	22	450 0.5×	241 0.5×	488 2.3×	153 0.9×	46 0.3×	30	1.2k
Ga‐Young Ban South Korea	21	323 0.4×	602 1.3×	168 0.8×	332 1.9×	266 1.6×	71	1.2k
Atsushi Otsuka Japan	22	517 0.6×	112 0.2×	271 1.3×	171 1.0×	335 2.1×	147	1.7k
Donglei Zhang China	21	301 0.3×	86 0.2×	404 1.9×	180 1.1×	67 0.4×	87	1.3k
Takanori Numata Japan	16	514 0.6×	358 0.8×	275 1.3×	111 0.6×	27 0.2×	44	994
Satoru Doi Japan	18	182 0.2×	462 1.0×	322 1.5×	477 2.8×	100 0.6×	37	1.2k

Countries citing papers authored by Abhya Gupta

Since Specialization

Citations

This map shows the geographic impact of Abhya Gupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abhya Gupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abhya Gupta more than expected).

Fields of papers citing papers by Abhya Gupta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abhya Gupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abhya Gupta. The network helps show where Abhya Gupta may publish in the future.

Co-authorship network of co-authors of Abhya Gupta

This figure shows the co-authorship network connecting the top 25 collaborators of Abhya Gupta. A scholar is included among the top collaborators of Abhya Gupta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abhya Gupta. Abhya Gupta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Yufei, et al.. (2025). Cells prioritize the regulation of cell mass density. Science Advances. 11(35). eadv9759–eadv9759. 1 indexed citations

Zheng, Peng, et al.. (2025). Spectrally Silent and Optically Transparent: Clear-SiR for Deep Raman Biomolecular Sensing. ACS Sensors. 10(10). 7702–7711.

Gupta, Abhya, et al.. (2025). Single–cell Raman imaging reveals fructose impairs brown adipocyte differentiation. Biosensors and Bioelectronics. 290. 117994–117994. 1 indexed citations

Gupta, Abhya, Joo Ho Kim, Emanuela Saracino, et al.. (2025). Disordered Glass Nanowire Substrates Produce in Vivo‐Like Astrocyte Morphology Revealed by Low‐Coherence Holotomography. Advanced Science. 13(3). e13424–e13424.

Litzenburger, Tobias, Ramona Schmid, Xiao Ke, et al.. (2024). Transcriptomic characterization of the human segmental endotoxin challenge model. Scientific Reports. 14(1). 1721–1721. 1 indexed citations

Crapo, James D., Abhya Gupta, David A. Lynch, et al.. (2023). Baseline characteristics from a 3-year longitudinal study to phenotype subjects with COPD: the FOOTPRINTS study. Respiratory Research. 24(1). 290–290. 2 indexed citations

Vogel‐Claussen, Jens, Philipp Badorrek, Meike Müller, et al.. (2023). The effect of bradykinin 1 receptor antagonist BI 1026706 on pulmonary inflammation after segmental lipopolysaccharide challenge in healthy smokers. Pulmonary Pharmacology & Therapeutics. 82. 102246–102246. 1 indexed citations

Ware, Lorraine B., Nima Soleymanlou, Daniel F. McAuley, et al.. (2023). TRPC6 inhibitor (BI 764198) to reduce risk and severity of ARDS due to COVID-19: a phase II randomised controlled trial. Thorax. 78(8). 816–824. 4 indexed citations

Chalmers, James D., Abhya Gupta, Sanjay H. Chotirmall, et al.. (2023). A Phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: Airleaf. ERJ Open Research. 9(3). 633–2022. 22 indexed citations

10.

Campo, Ilaria, Federica Meloni, Martina Gahlemann, et al.. (2022). An exploratory study investigating biomarkers associated with autoimmune pulmonary alveolar proteinosis (aPAP). Scientific Reports. 12(1). 8708–8708. 3 indexed citations

11.

Crapo, James D., Abhya Gupta, David A. Lynch, et al.. (2021). FOOTPRINTS study protocol: rationale and methodology of a 3-year longitudinal observational study to phenotype patients with COPD. BMJ Open. 11(3). e042526–e042526. 2 indexed citations

12.

Goss, Christopher H., et al.. (2020). An innovative phase II trial to establish proof of efficacy and optimal dose of a new inhaled epithelial sodium channel inhibitor BI 1265162 in adults and adolescents with cystic fibrosis: BALANCE-CF^TM1. ERJ Open Research. 6(4). 395–2020. 9 indexed citations

13.

Singh, Dave, Naimat Ullah Khan, James Dean, et al.. (2019). FEV1 recovery following methacholine challenge in asthma: Variability and comparison of methods. Pulmonary Pharmacology & Therapeutics. 60. 101876–101876. 1 indexed citations

14.

Krug, Norbert, Abhya Gupta, Philipp Badorrek, et al.. (2013). Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis. Journal of Allergy and Clinical Immunology. 133(2). 414–419.e8. 47 indexed citations

15.

Richeldi, Luca, Ulrich Costabel, Moisés Selman, et al.. (2011). Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis. New England Journal of Medicine. 365(12). 1079–1087. 811 indexed citations breakdown →

16.

Blink, Bernt van den, Judith Branger, Sebastiaan Weijer, et al.. (2004). P38 Mitogen Activated Protein Kinase Is Involved in the Downregulation of Granulocyte CXC Chemokine Receptors 1 and 2 During Human Endotoxemia. Journal of Clinical Immunology. 24(1). 37–41. 17 indexed citations

17.

Wood, Chester C., Chan‐Loi Yong, Jeffrey B. Madwed, & Abhya Gupta. (2002). Safety, pharmacokinetics and pharmacodynamics of an oral p38 MAP kinase inhibitor (BIRB 796 BS), administered once daily for 7 days. Journal of Allergy and Clinical Immunology. 109(1). S321–S321. 2 indexed citations

18.

Branger, Judith, Bernt van den Blink, Sebastiaan Weijer, et al.. (2002). Anti-Inflammatory Effects of a p38 Mitogen-Activated Protein Kinase Inhibitor During Human Endotoxemia. The Journal of Immunology. 168(8). 4070–4077. 203 indexed citations

19.

Gupta, Abhya, Prashant Joshi, Saeed A. Jortani, et al.. (1997). A Case of Nondigitalis Cardiac Glycoside Toxicity. Therapeutic Drug Monitoring. 19(6). 711–714. 12 indexed citations

20.

Gupta, Abhya, et al.. (1997). ADVERSE DRUG REACTIONS FROM BIRTH TO EARLY CHILDHOOD. Pediatric Clinics of North America. 44(1). 79–92. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact